MME and Alzheimer disease: Similar to our in vivo data, losartan-treated 3xTg-AD APC displayed an enhanced expression of ChAT and reduced levels of BACE 1 shown by Western Blot (Figure 6a) concomitant to the increased number and intensity of neprilysin expression assessed by immunofluorescence (Figure 6b–d).